Table: Solasia Pharma -2020 group forecast(IFRS)
Dec 15 (Reuters) -
Solasia Pharma K. K.
CONSOLIDATED EARNINGS ESTIMATES
(in billions of yen unless specified)
Full Year to Full Year to
Dec 31, 2020 Dec 31, 2020
LATEST PREVIOUS
FORECAST FORECAST
Sales 450 mln
Operating loss 4.20
PreTax loss 4.20
Net loss 4.20
EPS Basic loss 35.78 yen
NOTE - Solasia Pharma K. K..(Figures are reported based on international accounting rules (IFRS).)
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4597.T